Daniel E. Greenleaf is CEO at BioScrip, Inc. (BIOS). They have made 7 open-market trades across 3 companies since 2006, most recently 2022-02-08.
CIK 0001208492
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
7 open-market purchases totalling $281K since 2006, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MODV | BUY | 2021-09-15 | 2021-09-17 | $172.85 | $201K | +8.9% | -4.2% | -21.6% |
| BIOS | BUY | 2017-11-09 | 2017-11-13 | $2.03 | $30K | +15.5% | +21.4% | +35.5% |
| BIOS | BUY | 2016-11-10 | 2016-11-14 | $1.30 | $21K | -2.1% | -22.9% | +15.0% |
| VQPH | BUY | 2007-02-16 | 2007-02-20 | $0.57 | $10K | N/A | N/A | N/A |
| VQPH | BUY | 2007-02-14 | 2007-02-16 | $0.58 | $1K | N/A | N/A | N/A |
| VQPH | BUY | 2006-04-04 | 2006-04-06 | $0.94 | $9K | N/A | N/A | N/A |
| VQPH | BUY | 2006-03-31 | 2006-04-03 | $0.85 | $9K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.